IJSTR

International Journal of Scientific & Technology Research

IJSTR@Facebook IJSTR@Twitter IJSTR@Linkedin
Home About Us Scope Editorial Board Blog/Latest News Contact Us
CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT
QR CODE
IJSTR-QR Code

IJSTR >> Volume 4 - Issue 8, August 2015 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



The Implementation Of The Pneumococcal Vaccine For Children Under 5 In Southeast Asia

[Full Text]

 

AUTHOR(S)

A.M. Crinnion, S. Karim, A. Ratzan, S. Young

 

KEYWORDS

 

ABSTRACT

Abstract- Pneumonia accounts for over 500,000 (19%) of deaths in children under 5 in the Southeast Asian Region, which is higher than notoriously deadly diseases such as malaria, measles, and HIV/AIDS (Rudan et al., 2008). By examining the challenges this region could have with the implementation of preventative methods (i.e. widespread vaccinations and educating natives), in combination with practices of non-profit organizations in other regions and with other diseases (i.e. GAVI Alliance, Expanded Program on Immunization), this research will aid in finding a cost-effective introduction of pneumonia vaccinations and other methods of combat with this disease in Southeast Asia.

 

REFERENCES

[1] Adegbola, Richard A. "Childhood Pneumonia As A Global Health Priority And The Strategic Interest, Bill & Melinda Gates Foundation." Clinical Infectious Diseases 54.(2012): 89-92. Academic Search Premier. Web. 27 July 2015.

[2] Clemens, John D., and Luis Jodar. "Translational Research to Assist Policy Decisions about Introducing New Vaccines in Developing Countries." Journal of Health, Population and Nutrition 22.3 (2004): 223-31. JSTOR. Web. 27 July 2015.

[3] Edejer, Tessa Tan-Torres, et al. "Achieving the Millennium Development Goals for Health: Cost Effectiveness Analysis of Strategies for Child Health in Developing Countries." BMJ: British Medical Journal 331.7526 (2005): 1177-80. JSTOR. Web. 27 July 2015.

[4] "GAVI Alliance Progress Report 2013." GAVI Alliance Progress Report 2013. N.p., 2013. Web. 29 July 2015.

[5] Ghimire, M., S.K. Bhattacharya, and J.P. Narain. “Pneumonia in South-East Asia Region: Public Health Perspective.” The Indian Journal of Medical Research 135.4 (2012): 459–468. Print.

[6] Greenwood, Brian, David Salisbury, and Adrian V.S. Hill. "Introduction: Vaccines and Global Health." Philosophical Transactions: Biological Sciences 366.1579 (2011): 2733-42. JSTOR. Web. 27 July 2015.

[7] Grijalva, Carlos G. and Kathryn M. Edwards. “Promises and Challenges of Pneumococcal Conjugate Vaccines for the Developing World.” Clinical Infectious Diseases 43.6 (2006): 680-682. Oxford University Press. Web. 27 July 2015.

[8] Hajjeh, Rana. "Accelerating Introduction of New Vaccines: Barriers to Introduction and Lessons Learned from the Recent Haemophilus Influenzae Type B Vaccine Experience." The Royal Society Publishing. N.p., 05 Sept. 2011. Web. 30 July 2015.

[9] Hajizadeh, Mohammad, et al. "Paid maternity leave and childhood vaccination uptake: Longitudinal evidence from 20 low-and-middle-income countries."Social Science & Medicine (2015).

[10] Henderson, Ralph H. "The Expanded Programme on Immunization of the World Health Organization." Reviews of Infectious Diseases 6.Supplement 2. International Symposium on Poliomyelitis Control (1984): S475-S479. JSTOR. Web. 27 July 2015.

[11] "Hib Initiative: A GAVI Success Story." - Gavi, the Vaccine Alliance. N.p., 2010. Web. 29 July 2015.

[12] "Immunizations, Vaccines and Biologicals." WHO. N.p., 2015. Web. 02 Aug. 2015.

[13] "Introduction of Pneumococcal Vaccine, PCV13, A Handbook for District and Health Facility Staff" (2013): n. pag. Web. 2 Aug. 2015.

[14] Levine, Orin S., et al. "Pneumococcal vaccination in developing countries." The Lancet 367.9526 (2006): 1880-1882. also works for organization and price

[15] "Overview." - ABOUT IFFIm. N.p., n.d. Web. 29 July 2015.

[16] Pakistan Pneumococcal Vaccine Introduction. Gavi, the Vaccine Alliance. Gavi, n.d. Web. 27 July 2015.

[17] Patrick L.F. Zuber, Ibrahim El-Ziq, Miloud Kaddar, Ann E. Ottosen, Katinka Rosenbaum, Meredith Shirey, Lidija Kamara, Philippe Duclos, “Sustaining GAVI-supported vaccine introductions in resource-poor countries.” Vaccine 29.17 (2011): 3149-54. Science Direct. Web. 27 July 2015.

[18] "Pneumonia." WHO. N.p., 2014. Web. 02 Aug. 2015.

[19] "Principles of Vaccination." Epidemiology and Prevention of Vaccine-Preventable Diseases. Ed. Jennifer Hamborsky, Andrew Kroger, and Charles Wolfe. 13th ed. Washington DC: Public Health Foundation, 2015. 1-8. Centers for Disease Control and Prevention. Web. 2 Aug. 2015.

[20] "Protecting People from Vaccine Preventable Diseases" (n.d.): n. pag. Web. 30 July 2015.

[21] Rudan, Igor, et al. "Epidemiology and Etiology of Childhood Pneumonia." Bulletin of the World Health Organization 86.5 (2008): n. pag. World Health Organization. Web. 27 July 2015.

[22] SEAR ITAG. “Third Meeting of the South-East Asia Regional Immunization Technical Advisory Group (SEAR ITAG)” (2012): n. pag. Web. 2 Aug. 2015.

[23] "Taxation in Southeast Asia: An Overview | Lexology." Taxation in Southeast Asia: An Overview. N.p., 2014. Web. 02 Aug. 2015.

[24] "The Expanded Programme on Immunization." World Health Organization. N.p., n.d., 01 December 2013. Web. 28 July 2015.

[25] V. Višekruna Vučina, S. Kurečić Filipović, N. Kožnjak, V. Stamenić, A.D. Clark, B. Mounaud, J. Blau, C. Hoestlandt, B. Kaić, "Cost-effectiveness of Pneumococcal Conjugate Vaccination in Croatia." Vaccine 33.1 (2015): A209-218. Science Direct. Web. 27 July 2015.

[26] You, Joyce HS, et al. "Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities."Journal of epidemiology and community health 63.11 (2009): 906-911. also some systematic